Effect of heparin treatment on antithrombin IIi (AT III) activity
Mach, U.; Puzyna, W.
Ginekologia Polska 58(8): 544-547
1987
ISSN/ISBN: 0017-0011 PMID: 3428662 Document Number: 304272
Document emailed within 1 workday
Related Documents
Bergmann, H.; Blauhut, B.; Necek, S.; Kramar, H.; Vinazzer, H. 1980: Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin IIi Der Anaesthesist 29(11): 623-626Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Nakagawa, M.; Okada, T.; Okuda, S.; Nishizawa, A.; Watada, M. 1977: Exogenous heparin and antithrombin activity Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 40(2): 207-212
Zhang, L.; Zhang, G. 1999: Thrombosis induced by homocysteine does not depend on platelet aggregation or heparin cofactor's antithrombin activity Hunan Yi Ke da Xue Xue Bao 24(4): 309
Raper, C.G.; Love, H. 1978: Heparin-neutralizing activity, total progressive antithrombin and ethanol gel test in acute chest pain Thrombosis and Haemostasis 40(2): 418-422
Petitou, M.; Lormeau, J.C.; Choay, J. 1991: A new synthetic pentasaccharide with increased anti-factor Xa activity: possible role for anionic clusters in the interaction of heparin and antithrombin IIi Seminars in Thrombosis and Hemostasis 17(Suppl 2): 143-146
Dietrich, W.; Schroll, A.; Göb, E.; Barankay, A.; Richter, J.A. 1984: Antithrombin IIi substitution for optimization of the heparin effect during extracorporeal circulation in heart surgery Der Anaesthesist 33(9): 422-427
Psuja, P. 1988: Effect of antithrombin IIi on the binding of heparin and its low molecular weight fraction CY 216 with endothelium in vitro Acta Haematologica Polonica 19(3-4): 143-149
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Levy, S.W.; Jaques, L.B. 1978: Appearance of heparin antithrombin-active chains in vivo after injection of commercial heparin and in anaphylaxis Thrombosis Research 13(3): 429-441
Brieger, D.; Dawes, J. 1996: Long-term persistence of biological activity following administration of Enoxaparin sodium (clexane) is due to sequestration of antithrombin-binding low molecular weight fragments--comparison with unfractionated heparin Thrombosis and Haemostasis 75(5): 740-746
Gallus, A.S.; Goodall, K.T.; Tillett, J.; Jackaman, J.; Wycherley, A. 1987: The relative contributions of antithrombin III during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism Thrombosis Research 46(4): 539-553
Kondo, S.; Niwa, M. 1985: Antithrombin IIi and heparin cofactor Ii Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 61: 106-113
Akai, Y.; Shiga, S.; Tohyama, K.; Shimatsu, A.; Ichiyama, S. 2000: Effect of heparin cofactor Ii on the antithrombin IIi activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women Rinsho Byori. Japanese Journal of Clinical Pathology 48(9): 867-871
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Riensenfeld, J.; Höök, M.; Björk, I.; Lindahl, U.; Ajaxon, B. 1977: Structural requirements for the interaction of heparin with antithrombin IIi Federation Proceedings 36(1): 39-43
Aiach, M.; Fiessinger, J.N.; Andreux, J.P.; Beuvin, J.; Housset, E.; Leclerc, M. 1977: Electrophoretic mobility of antithrombin IIi in an agarose gel with heparin Pathologie-Biologie 25 Suppl: 35-41
Gandolfo, G.M.; Torresi, M.V. 1978: The influence of heparin on the immunochemical evaluation of antithrombin IIi by electroimmunoassay Haematologica 63(5): 512-520
Okajima, K.; Ueyama, H.; Hashimoto, Y.; Sasaki, Y.; Matsumoto, K.; Okabe, H.; Inoue, M.; Araki, S.; Takatsuki, K. 1989: Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto Thrombosis and Haemostasis 61(1): 20-24
Mortensen, S.A.; Remvig, L.; Als, O.S.; Andreasen, T. 1983: Antithrombin IIi (AT-III) and low dosage heparin therapy. the prognostic value of AT-IIi in acute myocardial infarction Ugeskrift for Laeger 145(14): 1056-1059